<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02322840</url>
  </required_header>
  <id_info>
    <org_study_id>MDT19042TMV002</org_study_id>
    <nct_id>NCT02322840</nct_id>
  </id_info>
  <brief_title>Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study &amp; EFS of the TMVR Transseptal System</brief_title>
  <official_title>An Initial Evaluation of the Safety and Performance of the Transcatheter Mitral Valve Replacement System in Patients With Severe, Symptomatic Mitral Regurgitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PILOT:&#xD;
&#xD;
      The study is pilot trial to evaluate the safety and performance of the Twelve TMVR System in&#xD;
      very high risk mitral regurgitation patients.&#xD;
&#xD;
      EFS:&#xD;
&#xD;
      The study is an EFS trial to evaluate the safety and performance of the Medtronic Intrepid™&#xD;
      Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal access in&#xD;
      Patients with Severe, Symptomatic Mitral Regurgitation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PILOT:&#xD;
&#xD;
      The study is a prospective, multi-center, non-randomized trial to evaluate the safety and&#xD;
      performance of the Twelve TMVR System in very high risk patients with severe, symptomatic&#xD;
      mitral regurgitation, who are deemed ineligible for standard surgery.&#xD;
&#xD;
      EFS:&#xD;
&#xD;
      The study is a multi-center, prospective, non-randomized, trial to evaluate the safety and&#xD;
      performance of the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System with&#xD;
      Transfemoral Transseptal access in Patients with Severe, Symptomatic Mitral Regurgitation&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patients with adverse events associated with the delivery and/or implantation of the device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural Success (Number of patients with successful TMVR placement)</measure>
    <time_frame>Through 5 years</time_frame>
    <description>Number of patients with successful TMVR placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of MR (Number of patients with a reduction of MR Grade)</measure>
    <time_frame>Through 5 years</time_frame>
    <description>Number of patients with a reduction of MR Grade</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Mitral Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>TMVR Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twelve TMVR Implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Twelve TMVR Implant</intervention_name>
    <description>Implantation of the Twelve TMVR System</description>
    <arm_group_label>TMVR Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Severe mitral regurgitation (MR Grade 3-4+)&#xD;
&#xD;
          -  Symptomatic mitral regurgitation (NYHA Class II-IV)&#xD;
&#xD;
          -  Trans-apical access deemed feasible by the treating physician (PILOT only)&#xD;
&#xD;
          -  Subjects anatomically suitable for the Intrepid TMVR delivery system including&#xD;
             transfemoral and transseptal access (EFS only)&#xD;
&#xD;
          -  Native mitral valve geometry and size compatible with the Twelve TMVR/Intrepid&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Left ventricular ejection fraction (LVEF) &lt; 20 (PILOT) or &lt;25% (EFS)&#xD;
&#xD;
          -  Evidence of intracardiac mass, thrombus, or vegetation&#xD;
&#xD;
          -  Prior valve surgery or need for other valve surgery&#xD;
&#xD;
          -  Prior stroke within 4 weeks (PILOT) or 90 days (EFS)&#xD;
&#xD;
          -  Prior myocardial infarction within 6 months (PILOT) or 90 days (EFS)&#xD;
&#xD;
          -  Need for coronary revascularization&#xD;
&#xD;
          -  History of, or active, endocarditis&#xD;
&#xD;
          -  Renal insufficiency (Creatinine &gt; 2.5 mg/dL)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Brown</last_name>
    <role>Study Director</role>
    <affiliation>Medtronic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Brown</last_name>
    <email>RS.tmvrtwelvepilotstudy@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Abrazo Arizon Heart Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Byrne</last_name>
      <email>JESSICA.BYRNE@abrazohealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelley Holt</last_name>
      <email>Shelley.Holt@piedmont.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Helm</last_name>
      <email>Elizabeth.Helm@spectrumhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sorajja Paul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Gaudio</last_name>
      <email>stephanie.gaudio@nyulangone.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fusilero</last_name>
      <email>michael.fusilero@mountsinai.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deniz Akkoc</last_name>
      <email>da2454@columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health Sciences University Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelsey Cameron</last_name>
      <email>cameronk@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Pinnacle Harrisburg</name>
      <address>
        <city>Wormleysburg</city>
        <state>Pennsylvania</state>
        <zip>17043</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regina Hollister</last_name>
      <email>hollisterr@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Virginia Medical Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Bryceland</last_name>
      <email>lgs2m@hscmail.mcc.virginia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Bennett</last_name>
      <email>michelle.bennett@aurora.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monash Health</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Alfred</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Helsinki Univesity Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hygeia Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Brighton and Sussex</name>
      <address>
        <city>Brighton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Leeds Teaching Hospitals</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Thomas' Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Greece</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 31, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

